Comment on 'Clinical significance of BRAF non-V600E mutations on the therapeutic effects of anti-EGFR monoclonal antibody treatment in patients with pretreated metastatic colorectal cancer: the Biomarker Research for anti-EGFR monoclonal Antibodies by Comprehensive Cancer genomics (BREAC) study'

被引：3
|
作者：
Dankner, Matthew [1 ,2 ]
Rose, April A. N. [3 ]
机构：
[1] McGill Univ, Goodman Canc Res Ctr, Montreal, PQ, Canada
[2] McGill Univ, Dept Med, Montreal, PQ, Canada
[3] Univ Toronto, Dept Med, Div Med Oncol, Toronto, ON, Canada
来源：
BRITISH JOURNAL OF CANCER | 2018年 / 118卷 / 09期
关键词：
RAS MUTATIONS;
D O I：
10.1038/s41416-018-0012-2
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1276 / 1277
页数：2
相关论文
共 50 条
  • [31] Epidermal growth factor receptor (EGFR) and KRAS mutations during chemotherapy plus anti-EGFR monoclonal antibody treatment in metastatic colorectal cancer
    Tougeron D.
    Cortes U.
    Ferru A.
    Villalva C.
    Silvain C.
    Tourani J.M.
    Levillain P.
    Karayan-Tapon L.
    Cancer Chemotherapy and Pharmacology, 2013, 72 (2) : 397 - 403
  • [32] BRAF mutation predicts resistance to anti-EGFR monoclonal antibodies in wild-type KRAS metastatic colorectal cancer
    Chen Mao
    Ru-Yan Liao
    Qing Chen
    Journal of Cancer Research and Clinical Oncology, 2010, 136 : 1293 - 1294
  • [33] BRAF mutation predicts resistance to anti-EGFR monoclonal antibodies in wild-type KRAS metastatic colorectal cancer
    Mao, Chen
    Liao, Ru-Yan
    Chen, Qing
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2010, 136 (08) : 1293 - 1294
  • [34] The Prognostic Role of BRAF Mutation in Metastatic Colorectal Cancer Receiving Anti-EGFR Monoclonal Antibodies: A Meta-Analysis
    Yuan, Zi-Xu
    Wang, Xiao-Yan
    Qin, Qi-Yuan
    Chen, De-Feng
    Zhong, Qing-Hua
    Wang, Lei
    Wang, Jian-Ping
    PLOS ONE, 2013, 8 (06):
  • [35] Anti-EGFR monoclonal antibody panitumumab for the treatment of patients with metastatic colorectal cancer: an overview of current practice and future perspectives
    Battaglin, Francesca
    Dadduzio, Vincenzo
    Bergamo, Francesca
    Manai, Chiara
    Schirripa, Marta
    Lonardi, Sara
    Zagonel, Vittorina
    Loupakis, Fotios
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2017, 17 (10) : 1297 - 1308
  • [36] Dynamics of RAS/BRAF Mutations in cfDNA from Metastatic Colorectal Carcinoma Patients Treated with Polychemotherapy and Anti-EGFR Monoclonal Antibodies
    Rachiglio, Anna Maria
    Forgione, Laura
    Pasquale, Raffaella
    Barone, Carlo Antonio
    Maiello, Evaristo
    Antonuzzo, Lorenzo
    Cassata, Antonino
    Tonini, Giuseppe
    Bordonaro, Roberto
    Rosati, Gerardo
    Zaniboni, Alberto
    Lonardi, Sara
    Ferrari, Daris
    Frassineti, Giovanni Luca
    Tamberi, Stefano
    Pisconti, Salvatore
    Di Fabio, Francesca
    Roma, Cristin
    Orlandi, Armando
    Latiano, Tiziana
    Damato, Angela
    Tortora, Giampaolo
    Pinto, Carmine
    Normanno, Nicola
    CANCERS, 2022, 14 (04)
  • [37] Increased Detection Sensitivity for KRAS Mutations Enhances the Prediction of Anti-EGFR Monoclonal Antibody Resistance in Metastatic Colorectal Cancer
    Molinari, Francesca
    Felicioni, Lara
    Buscarino, Michela
    De Dosso, Sara
    Buttitta, Fiamma
    Malatesta, Sara
    Movilia, Alessandra
    Luoni, Marco
    Boldorini, Renzo
    Alabiso, Oscar
    Girlando, Salvatore
    Soini, Barbara
    Spitale, Alessandra
    Di Nicolantonio, Federica
    Saletti, Piercarlo
    Crippa, Stefano
    Mazzucchelli, Luca
    Marchetti, Antonio
    Bardelli, Alberto
    Frattini, Milo
    CLINICAL CANCER RESEARCH, 2011, 17 (14) : 4901 - 4914
  • [38] Systems approach for the selection of micro-RNAs as therapeutic biomarkers of anti-EGFR monoclonal antibody treatment in colorectal cancer
    Deyati, Avisek
    Bagewadi, Shweta
    Senger, Philipp
    Hofmann-Apitius, Martin
    Novac, Natalia
    SCIENTIFIC REPORTS, 2015, 5 : 8013
  • [39] Systems approach for the selection of micro-RNAs as therapeutic biomarkers of anti-EGFR monoclonal antibody treatment in colorectal cancer
    Avisek Deyati
    Shweta Bagewadi
    Philipp Senger
    Martin Hofmann-Apitius
    Natalia Novac
    Scientific Reports, 5
  • [40] The clinical significance of the gut microbiota in RAS wildtype metastatic colorectal cancer patients treated with anti-EGFR monoclonal antibodies in combination with chemotherapy - preliminary results
    Lewandowski, T.
    Stelmasiak, P.
    Nska, J. Stefa
    Wolinowska, R.
    Bobrowska, B.
    Laskowska, A.
    ANNALS OF ONCOLOGY, 2021, 32 : S185 - S185
12345